or Try an Advanced Search...

    Technical Analysis for BJDX - Bluejay Diagnostics, Inc.

    Grade Last Price % Change Price Change
    F 0.71 0.87% 0.01
    BJDX closed up 0.87 percent on Monday, July 1, 2024, on 3.8 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical BJDX trend table...
    Date Alert Name Type % Chg
    Volume Surge Other 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 0.87%
    Volume Surge Other 0.87%
    NR7 Range Contraction 0.87%
    NR7-2 Range Contraction 0.87%
    Older End-of-Day Signals for BJDX ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 6 hours ago
    Up 2% about 6 hours ago
    Up 1% about 9 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    Down 5% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    BJDX Chart by TradingView
    Basic chart:

    Profile

    Bluejay Diagnostics, Inc. Description

    Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

    Classification
    Sector: Healthcare
    Industry: Medical Devices
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Infectious Diseases Inflammation Biomarkers Allergy Chemical Pathology Allergic Conjunctivitis Congestive Heart Failure Sepsis Conjunctivitis Lyme Disease Tick Borne Diseases

    Is BJDX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering
    Jun 27 Top Midday Decliners
    Jun 27 Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering
    Jun 26 SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
    Jun 17 Bluejay Diagnostics announces 1-for-8 reverse stock split
    Jun 17 Bluejay Diagnostics Announces Reverse Stock Split
    May 24 BJDX: 1Q:24 Financial Update
    Apr 9 BJDX: 2023 Financial Update
    Jan 29 Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
    Jan 2 Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
    See more BJDX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 111.8392
    52 Week Low 0.64
    Average Volume 258,267
    200-Day Moving Average 14.00
    50-Day Moving Average 3.85
    20-Day Moving Average 3.16
    10-Day Moving Average 2.25
    Average True Range 0.65
    RSI (14) 20.63
    ADX 30.58
    +DI 12.51
    -DI 51.77
    Chandelier Exit (Long, 3 ATRs) 4.39
    Chandelier Exit (Short, 3 ATRs) 2.59
    Upper Bollinger Bands 5.69
    Lower Bollinger Band 0.63
    Percent B (%b) 0.01
    BandWidth 159.94
    MACD Line -0.83
    MACD Signal Line -0.53
    MACD Histogram -0.3032
    Fundamentals Value
    Market Cap 1.25 Million
    Num Shares 1.78 Million
    EPS -9.64
    Price-to-Earnings (P/E) Ratio -0.07
    Price-to-Sales 34.80
    Price-to-Book 0.26
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.83
    Resistance 3 (R3) 0.82 0.77 0.81
    Resistance 2 (R2) 0.77 0.74 0.78 0.80
    Resistance 1 (R1) 0.74 0.72 0.75 0.75 0.79
    Pivot Point 0.69 0.69 0.70 0.69 0.69
    Support 1 (S1) 0.66 0.66 0.67 0.66 0.62
    Support 2 (S2) 0.61 0.64 0.61 0.61
    Support 3 (S3) 0.57 0.61 0.60
    Support 4 (S4) 0.58